The Antitrust has extended to the companies Fenice and TBS Crew, attributable to Chiara Ferragni, the proceeding initiated against the Balocco confectionery industry for unfair commercial practice in relation to the commercial initiative called Chiara Ferragni and Balocco together for the Regina Margherita hospital in Turin . The competition and market authority itself broke the news, announcing that its officials carried out inspections in the Fenice and TBS Crew offices with the help of the special Antitrust unit of the Guardia di Finanza.
The Antitrust investigation
Between November and December 2022, Balocco had put Ferragni's limited edition pandoro on sale to support research on osteosarcoma and Ewing's sarcoma in favor of the Regina Margherita Hospital in Turin. On 14 June, the Authority communicated the start of an investigation into an unfair commercial practice against the confectionery company. According to the Antitrust, the way the initiative was presented could mislead consumers. According to the authority, in fact, both from the press releases and from the writings on the pandoro packaging, consumers could be led to believe that by buying the Ferragni-branded product they were contributing to the donation to the Regina Margherita hospital in Turin. While Balocco had made a fixed-cost donation to the hospital several months before the advertising launch of the initiative and therefore completely independently of the product's sales performance, explained the Agcm.